Augmedix, Inc. to Ring Nasdaq Closing Bell Today
Augmedix recently celebrated its successful uplisting to Nasdaq under the ticker AUGX, marking a significant milestone for the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Augmedix recently celebrated its successful uplisting to Nasdaq under the ticker AUGX, marking a significant milestone for the company. CEO Manny Krakaris, accompanied by the Augmedix team and shareholders, rang the closing bell at Nasdaq MarketSite in New York's Times Square. The uplisting is seen as a critical step in Augmedix's mission to lead in virtual medical documentation through its Ambient Automation Platform, designed to alleviate documentation burdens on healthcare providers. The platform aims to enhance productivity and improve patient care.
Positive
- Successful uplisting to Nasdaq enhances credibility and market visibility.
- CEO's public engagement at Nasdaq may boost investor confidence.
- The Ambient Automation Platform aims to save physicians up to 3 hours a day and improve productivity by 20%.
Negative
- None.
Details
News Market Reaction – AUGX
The recorded move for AUGX in the trading session of this news was -0.57%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Augmedix celebrates successful uplisting to Nasdaq and public offering
NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- AUGMEDIX, Inc. (NASDAQ: AUGX) (“Augmedix” or the “Company”), a leading digital health platform that offers virtual medical documentation and live clinical support, announced today Manny Krakaris, Chief Executive Officer of Augmedix, will ring the closing bell, together with the Augmedix team and shareholders, at Nasdaq MarketSite in New York’s Times Square this afternoon at approximately 4:00 p.m. Eastern Time, in celebration of Augmedix’s uplisting on the Nasdaq.
The ceremony will begin at approximately 3:45 p.m. Eastern Time and can be viewed live here.
“Our recent uplisting marked an important milestone in the evolution of our company, and we want to thank the Augmedix team for their unwavering commitment to our mission. It is an honor to be ringing the Nasdaq closing bell on behalf of this team to commemorate this achievement,” said Mr. Krakaris. “As we continue to execute and deliver on our initiatives, our objective is to be the leader in virtual documentation with our Ambient Automation Platform and to deliver our transformative solution to enable relief and support to doctors from immense documentation burden and to effect better patient care as a result.”
About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) is a leading digital health platform that offers virtual medical documentation and live clinical support to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments and telemedicine practices nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists. Augmedix saves physicians up to 3 hours per day, improves productivity by as much as
Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.